Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of cyclopentolate hydrochloride 1% on pupil diameter and refractive error in Chinese children with dark brown irises
ChiCTR1900025774Phase 4Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclopentolate in ametropia, sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: pupil diameter and refractive error. Started Sep 2019; status: recruiting.
02
Drugs
cyclopentolate
03
Conditions
ametropia
Beyond the preview
Go deeper on ChiCTR1900025774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025774.